每年專案
個人檔案
學歷
- 2012 Ph.D. ISF College of Pharmacy, Punjab, India
- 2008 M.S. ISF College of Pharmacy, Punjab, India
- 2006 B.S. Rajiv Academy For Pharmacy. U.P,, India
經歷
- 2024.09 - Associate Editor, Journal of Enzyme Inhibition and Medicinal Chemistry (Taylor and Francis, Impact Factor - 5.6)
- 2023- Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical UniversityTaipei Medical University
- 2019-2023 Assistant Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2014-2019 Post-Doctoral Research Fellow, Taipei Medical University
- 2011-2014 Assistant Professor, Guru Nanak Dev University
- 2008-2011 Assistant Professor, Punjab Technical University
獎項
- Editorial Board Member, Medicinal Research Reviews (Wiley, Impact Factor - 10.9).
- Editorial board member - Mini Reviews in Medicinal chemistry (IF - 2.91, Chemistry/Medicinal)
- Plum Blossom Card (Permanent Resident Certificate) by Government of Taiwan 2020
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2018, Taipei Medical University, Taiwan.
Project title: The use of organometallic reaction in the synthesis of anticancer agents (2/2)
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2017, Taipei Medical University, Taiwan.
Project title: The use of organometallic reaction in the synthesis of anticancer agents
- Outstanding contribution in reviewing EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017.
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2016, Taipei Medical University, Taiwan.
Project title: Application of regioselective substitution on 1,4- Benzoquinone derivatives to provide potent anticancer agents
- Outstanding contribution in reviewing BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, 2016.
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2015, Taipei Medical University, Taiwan.
Project title: Preclinical development for novel HSP90 inhibitors as anticancer drugs
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2015, Taipei Medical University, Taiwan
Project title: Development of ITCHE3 ubiquitin ligase inhibitors as anticancer drug
研究興趣
- 天然物
- 有機合成
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
專案
- 7 已完成
-
-
Development of a retinoic-base histone deacetylase inhibitor as early-stage AMD treatment
Nepali, K. (PI)
7/1/23 → 2/29/24
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
標題:謹慎設計抗胃癌藥物:結構簡化方法、骨架躍遷策略以及對二氧化矽負載的質子酸/路易斯酸催化的多組分反應以產生關鍵中間體的詳盡探索
Nepali, K. (PI)
8/1/21 → 7/31/22
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
Contemporary approaches to mitigating antibacterial drug resistance
Grewal, A. S., Dhingra, A. K., Nepali, K., Deswal, G. & Srivastav, A. L., 4月 1 2024, IGI Global Publishing. 384 p.研究成果: 报告类型 › 書籍
-
Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress
Sharma, R., Chiang, Y. H., Chen, H. C., Lin, H. Y., Yang, W. B., Nepali, K., Lai, M. J., Chen, K. Y., Liou, J. P. & Hsu, T. I., 4月 1 2024, 於: Cancer Letters. 586, 216666.研究成果: 雜誌貢獻 › 文章 › 同行評審
2 引文 斯高帕斯(Scopus) -
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo
Sharma, S., Wang, S. A., Yang, W. B., Lin, H. Y., Lai, M. J., Chen, H. C., Kao, T. Y., Hsu, F. L., Nepali, K., Hsu, T. I. & Liou, J. P., 2月 22 2024, 於: Journal of Medicinal Chemistry. 67, 4, p. 2963-2985 23 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取3 引文 斯高帕斯(Scopus) -
Frontiers in combating antibacterial resistance: Current perspectives and future Horizons
Grewal, A. S., Dhingra, A. K., Nepali, K., Deswal, G. & Srivastav, A. L., 3月 25 2024, IGI Global Publishing. 422 p.研究成果: 报告类型 › 書籍
-
Leveraging a rationally designed veliparib-based anilide eliciting anti-leukemic effects for the design of pH-responsive polymer nanoformulation
Thakur, A., Chu, Y. H., Rao, N. V., Mathew, J., Grewal, A. S., Prabakaran, P., Guru, S., Liou, J. P., Pan, C. H. & Nepali, K., 7月 5 2024, 於: European Journal of Medicinal Chemistry. 273, 116507.研究成果: 雜誌貢獻 › 文章 › 同行評審
1 引文 斯高帕斯(Scopus)
資料集
-
Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors
Virdi, H. S. (Creator), Sharma, S. (Contributor), Mehndiratta, S. (Creator), Bedi, P. M. S. (Contributor) & Nepali, K. (Contributor), Figshare, 2015
DOI: 10.6084/m9.figshare.1568378.v1, https://figshare.com/articles/Design_synthesis_and_evaluation_of_2_4_diarylpyrano_3_2_c_chromen_5_4H_one_as_a_new_class_of_non_purine_xanthine_oxidase_inhibitors/1568378/1
資料集: Dataset